US Broker Ratings

Astrana Health Inc. (ASTH)

⚠️ No article content returned.

..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: A 51.74% Upside Potential Awaits Investors

GoodRx Holdings, Inc. (NASDAQ: GDRX) presents an intriguing opportunity for investors seeking exposure to the healthcare sector, particularly in the health information services industry. With a..

NovoCure Limited (NVCR) Stock Analysis: Exploring a Potential 91.78% Upside

NovoCure Limited (NASDAQ: NVCR), a promising player in the healthcare sector, is drawing investor attention with its innovative approach to cancer treatment. As a Swiss medical..

LifeStance Health Group, Inc. (LFST) Stock Analysis: A 36% Potential Upside Beckons Investors

LifeStance Health Group, Inc. (LFST) is making waves in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Scottsdale, Arizona, LifeStance provides vital..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring an 83.57% Potential Upside in Biotech Innovation

As investors continue to navigate the turbulent waters of the biotechnology sector, Celldex Therapeutics, Inc. (NASDAQ: CLDX) presents an intriguing opportunity with a notable potential upside..

Centessa Pharmaceuticals plc (CNTA) Stock Analysis: A 49.54% Potential Upside Beckons Investors

Centessa Pharmaceuticals plc (NASDAQ: CNTA) offers an intriguing opportunity for investors seeking exposure to the innovative and high-growth potential of the biotechnology sector. With a market..

Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 54% Potential Upside in the Healthcare Sector

Clover Health Investments, Corp (NASDAQ: CLOV) has been a focal point for investors in the healthcare sector, particularly those interested in companies that blend technology with..

GRAIL, Inc. (GRAL) Stock Analysis: Investor Outlook on a 67.21% Potential Upside

Investors are increasingly turning their attention to GRAIL, Inc. (GRAL), a pioneering healthcare company that is making significant strides in the diagnostics and research industry. With..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring a 46.68% Potential Upside Amidst Strong Buy Ratings

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a Netherlands-based biopharmaceutical firm, is currently capturing investor attention with its significant growth potential and a robust lineup of analyst..

CG Oncology, Inc. (CGON) Stock Analysis: A 39% Potential Upside in the Battle Against Bladder Cancer

CG Oncology, Inc. (NASDAQ: CGON) stands as a formidable player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $4.77 billion,..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring the 316.79% Potential Upside

For investors seeking high-growth opportunities in the biotechnology sector, Janux Therapeutics, Inc. (NASDAQ: JANX) offers an intriguing proposition with its remarkable potential upside. As a clinical-stage..

Ascentage Pharma Group Internat (AAPG): Investor Outlook on a Biotech Innovator with 108% Upside Potential

Ascentage Pharma Group International (AAPG), a pioneering force in the biotechnology industry, is capturing investor attention with its ambitious pipeline of therapies poised to address critical..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Gem with 15.82% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK), a budding entity in the biotechnology landscape, commands attention with its promising pipeline and a robust market cap of $4.44..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a 145% Upside Potential Amidst Strong Analyst Support

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is capturing investor attention with its ambitious pipeline and potential for significant upside. As a biotechnology company focused on rare and..

Beam Therapeutics Inc. (BEAM): Investor Outlook with 74% Potential Upside in the Biotech Sector

Beam Therapeutics Inc. (NASDAQ: BEAM) is making waves in the biotechnology sector with its precision genetic medicines, targeting serious diseases through innovative therapies. With a market..

Acadia Healthcare (ACHC) Stock Analysis: A Closer Look at its Challenges and Potential Amidst a -3.10% Upside

Investors interested in the healthcare sector, particularly the niche market of behavioral healthcare services, may find Acadia Healthcare Company, Inc. (NASDAQ: ACHC) a noteworthy candidate. With..

Brookdale Senior Living Inc. (BKD): Investor Outlook Highlights 28% Upside Potential

Brookdale Senior Living Inc. (BKD) is a pivotal player in the healthcare sector, specifically within the medical care facilities industry in the United States. With a..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Exploring a 178% Upside Potential

Viking Therapeutics, Inc. (NASDAQ: VKTX) has emerged as a compelling player in the biotechnology sector, capturing the attention of investors with its innovative pipeline and substantial..

PACS Group, Inc. (PACS) Stock Analysis: A Promising 20.63% Upside in the Healthcare Sector

PACS Group, Inc. (PACS), a prominent player in the healthcare sector, is capturing investor attention with its impressive potential upside of 20.63%. Specializing in the operation..

Alvotech (ALVO) Stock Analysis: Exploring a Potential 375% Upside in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based company specializing in the development and manufacture of biosimilar medicines, has caught the attention of investors with its promising growth potential...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds